• Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
Skip to content
  • Facebook
  • Twitter
  • LinkedIn
  • Google News
BioPharma Media

BioPharma Media

Biopharmaceutical industry analysis.
 Credible, reliable, equitable.

  • Topic
    • COVID-19
    • New Drugs
    • Oncology
    • Metabolism
    • Neuroscience
    • Autoimmune Diseases
    • Infections
    • Rare/Orphan Diseases
    • Drug Safety
  • Section
    • Pharma & Biotech
    • Regulatory
    • Clinical Trials
    • Mergers & Acquisitions
    • Research
    • In the Pipeline
  • BioPharma Media
    • About Us
    • Our Team
    • Contact Us
    • Editorial Policy
    • Terms of Use
    • Privacy Policy

Sanofi

Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus
Posted inInfections, New Drugs, Regulatory

Beyfortus: Effective Protection for Infants Against Respiratory Syncytial Virus

September 17, 2022September 20, 2022

One injection of nirsevimab reliably protects newborns against the development of RSV-associated lower respiratory tract infections.

insulin
Posted inAutoimmune Diseases, Clinical Trials, Metabolism

Insulin Icodec: Basal Insulin Once a Week

August 6, 2022September 8, 2022

Novo Nordisk will offer a very patient-friendly weekly version of insulin.

weight-loss-pills
Posted inClinical Trials, In the Pipeline, Metabolism

Most Effective Weight Loss Drugs: Present and Future

July 3, 2022September 20, 2022

Modern pharmacological ways to combat obesity.

brain
Posted inAutoimmune Diseases, Clinical Trials, Neuroscience

Ublyxi: Highly Effective Drug for Multiple Sclerosis

May 31, 2022September 8, 2022

Ublituximab is the third anti-CD20 therapy for multiple sclerosis and a worthy rival to Ocrevus and Kesimpta.

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus
Posted inMetabolism, New Drugs, Regulatory

Mounjaro: New Dual-Action Drug for Type 2 Diabetes Mellitus

May 17, 2022September 8, 2022

Tirzepatide by Eli Lilly is a powerful new antidiabetic drug.

Enjaymo: First Drug to Treat Cold Agglutinin Disease
Posted inAutoimmune Diseases, New Drugs, Rare/Orphan Diseases, Regulatory

Enjaymo: First Drug to Treat Cold Agglutinin Disease

February 9, 2022September 8, 2022

Sutimlimab will reduce the need for red blood cell transfusion due to hemolysis.

Treating Parkinson’s Disease: Betting on Alpha-Synuclein
Posted inClinical Trials, In the Pipeline, Neuroscience

Treating Parkinson’s Disease: Betting on Alpha-Synuclein

January 14, 2022September 8, 2022

The pharmaceutical industry continues to fight hard against the devastating neurodegenerative disease.

Posts navigation

1 2 Older posts
BioPharma Media Logo
Biopharmaceutical industry analysis.
© 2023 BioPharma Media. Newspack by Automattic. The end-to-end solution. Privacy Policy
  • Facebook
  • Twitter
  • LinkedIn
  • Google News